Abstract

AbstractRadioembolization has gained wide acceptance as a safe and efficient treatment for unresectable liver-dominant metastatic colorectal cancer. In this comprehensive article, we focus on clinical outcomes and dosimetry models in the era of personalized medicine.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call